Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Bussel

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Blood Advances|October 15, 2021
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitroZhi-Jian Liu, Emoke Deschmann, Haley E Ramsey, et al.
Journal of Clinical Apheresis|August 18, 2022
Therapeutic plasma exchange practices in immune thrombocytopenia related hospitalizations: Results from a nationally representative sampleSarah S Makhani, Joseph Schwartz, Ljiljana V Vasovic, et al.
Pediatric Blood & Cancer|January 11, 2024
Does anti-HPA-1a affect birthweight in fetal and neonatal alloimmune thrombocytopenia?Margaret McKelvy, Srishti Tyagi, Emilie Vander Haar, et al.
Thrombosis Research|December 6, 2019
Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonistsLamya Garabet, Carola E Henriksson, María Luisa Lozano, et al.
Emerging Infectious Diseases|July 18, 2018
Death from Transfusion-Transmitted Anaplasmosis, New York, USA, 2017Ruchika Goel, Lars F Westblade, Debra A Kessler, et al.
Transfusion|December 7, 2018
Platelet transfusion practices in immune thrombocytopenia related hospitalizationsRuchika Goel, Saurav Chopra, Aaron A R Tobian, et al.
American Journal of Hematology|April 27, 2018
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trialsJames Bussel, Donald M Arnold, Elliot Grossbard, et al.
British Journal of Haematology|January 8, 2025
MicroRNA-199a-5p may be a diagnostic biomarker of primary ITPLamya Garabet, Anbjørg Rangberg, Anna Maria Eriksson, et al.
American Journal of Hematology|June 4, 2026
Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0Nichola Cooper, James Bussel, Waleed Ghanima, et al.
Blood|April 28, 2012
Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopeniaCassandra D Josephson, Suzanne Granger, Susan F Assmann, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Blood Advances|October 15, 2021
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitroZhi-Jian Liu, Emoke Deschmann, Haley E Ramsey, et al.
Journal of Clinical Apheresis|August 18, 2022
Therapeutic plasma exchange practices in immune thrombocytopenia related hospitalizations: Results from a nationally representative sampleSarah S Makhani, Joseph Schwartz, Ljiljana V Vasovic, et al.
Pediatric Blood & Cancer|January 11, 2024
Does anti-HPA-1a affect birthweight in fetal and neonatal alloimmune thrombocytopenia?Margaret McKelvy, Srishti Tyagi, Emilie Vander Haar, et al.
Thrombosis Research|December 6, 2019
Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonistsLamya Garabet, Carola E Henriksson, María Luisa Lozano, et al.
Emerging Infectious Diseases|July 18, 2018
Death from Transfusion-Transmitted Anaplasmosis, New York, USA, 2017Ruchika Goel, Lars F Westblade, Debra A Kessler, et al.
Transfusion|December 7, 2018
Platelet transfusion practices in immune thrombocytopenia related hospitalizationsRuchika Goel, Saurav Chopra, Aaron A R Tobian, et al.
American Journal of Hematology|April 27, 2018
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trialsJames Bussel, Donald M Arnold, Elliot Grossbard, et al.
British Journal of Haematology|January 8, 2025
MicroRNA-199a-5p may be a diagnostic biomarker of primary ITPLamya Garabet, Anbjørg Rangberg, Anna Maria Eriksson, et al.
American Journal of Hematology|June 4, 2026
Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0Nichola Cooper, James Bussel, Waleed Ghanima, et al.
Blood|April 28, 2012
Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopeniaCassandra D Josephson, Suzanne Granger, Susan F Assmann, et al.
Pageof 6